Matches in Nanopublications for { ?s ?p "[Overall, the XRCC1 homozygous variant gln399gln genotype was related to a significantly reduced risk of both basal cell [BCC; odds ratio (OR) 0.7, 95% confidence interval 0.4-1.0] and squamous cell carcinoma (SCC; OR 0.6, 95% confidence interval 0.3-0.9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP780414.RAW_UWDc5QKt5qVEojLondCuZBk0zzRwNkabOwuifx9Ek130_assertion description "[Overall, the XRCC1 homozygous variant gln399gln genotype was related to a significantly reduced risk of both basal cell [BCC; odds ratio (OR) 0.7, 95% confidence interval 0.4-1.0] and squamous cell carcinoma (SCC; OR 0.6, 95% confidence interval 0.3-0.9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780414.RAW_UWDc5QKt5qVEojLondCuZBk0zzRwNkabOwuifx9Ek130_provenance.
- assertion description "[Overall, the XRCC1 homozygous variant gln399gln genotype was related to a significantly reduced risk of both basal cell [BCC; odds ratio (OR) 0.7, 95% confidence interval 0.4-1.0] and squamous cell carcinoma (SCC; OR 0.6, 95% confidence interval 0.3-0.9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP739533.RAO8Z2Fa-LOV5z3hwEr7b9c6xukWZeY3wzBMrOhPTjbjc130_assertion description "[Overall, the XRCC1 homozygous variant gln399gln genotype was related to a significantly reduced risk of both basal cell [BCC; odds ratio (OR) 0.7, 95% confidence interval 0.4-1.0] and squamous cell carcinoma (SCC; OR 0.6, 95% confidence interval 0.3-0.9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739533.RAO8Z2Fa-LOV5z3hwEr7b9c6xukWZeY3wzBMrOhPTjbjc130_provenance.
- NP341558.RAR1HkhM0eLYBsYHwo69q6JuFv-3YReObVPiaZ4O3SNwc130_assertion description "[Overall, the XRCC1 homozygous variant gln399gln genotype was related to a significantly reduced risk of both basal cell [BCC; odds ratio (OR) 0.7, 95% confidence interval 0.4-1.0] and squamous cell carcinoma (SCC; OR 0.6, 95% confidence interval 0.3-0.9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341558.RAR1HkhM0eLYBsYHwo69q6JuFv-3YReObVPiaZ4O3SNwc130_provenance.
- NP779683.RA-XOjSqtVfSFnFL6PC0Bn4vAopV2z-JRtxH6VaJkb_c0130_assertion description "[Overall, the XRCC1 homozygous variant gln399gln genotype was related to a significantly reduced risk of both basal cell [BCC; odds ratio (OR) 0.7, 95% confidence interval 0.4-1.0] and squamous cell carcinoma (SCC; OR 0.6, 95% confidence interval 0.3-0.9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779683.RA-XOjSqtVfSFnFL6PC0Bn4vAopV2z-JRtxH6VaJkb_c0130_provenance.
- NP341559.RA4420DriPcw_3xRMvdz4wiUWCWQ8K6rzcQ6pCKEkPebI130_assertion description "[Overall, the XRCC1 homozygous variant gln399gln genotype was related to a significantly reduced risk of both basal cell [BCC; odds ratio (OR) 0.7, 95% confidence interval 0.4-1.0] and squamous cell carcinoma (SCC; OR 0.6, 95% confidence interval 0.3-0.9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341559.RA4420DriPcw_3xRMvdz4wiUWCWQ8K6rzcQ6pCKEkPebI130_provenance.